SCHEMBL22486478

SCHEMBL22486478

CCOC(=O)[C@@H](C)OC(=O)[C@@H](C)OC(=O)[C@@H](C)OC(=O)[C@@H](C)OC(=O)[C@@H](C)OC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.39
LMNA P02545 2/20 0.37
HSD17B10 Q99714 2/20 0.37
ALOX15 P16050 3/20 0.36
GAA P10253 2/20 0.36
MGAM O43451 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
SOAT1 P35610 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
CYP3A4 P08684 3/20 0.34
CYP2C19 P33261 1/20 0.34
TRPA1 O75762 1/20 0.33
KMT2A Q03164 1/20 0.33
TSHR P16473 2/20 0.33
TDP1 Q9NUW8 1/20 0.33
CHRM1 P11229 1/20 0.32
ADORA1 P30542 1/20 0.32
HPGD P15428 1/20 0.32
PIN1 Q13526 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13235972 1.00 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10ALOX15GAA
SCHEMBL22486534 1.00 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10ALOX15GAA
SCHEMBL12951628 0.91
SCHEMBL8223259 0.91
SCHEMBL195331 0.91
SCHEMBL22486482 0.89 ALDH1A1 (0.31) ALDH1A1LMNAHSD17B10L3MBTL1CYP2C19
SCHEMBL15060631 0.84
SCHEMBL15744779 0.83 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10ALOX15GAA
SCHEMBL20511559 0.83 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10ALOX15GAA
SCHEMBL30104599 0.83 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10ALOX15GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200308162-A1 DRUGS AND COMPOSITIONS FOR OCULAR DELIVERY Graybug Vision, Inc. (US) 2020-10-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200308162-A1 DRUGS AND COMPOSITIONS FOR OCULAR DELIVERY AGER, PDE6B, PTGER1 ALDH1A1 385/4885LMNA 781/4885HSD17B10 1174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.